Charmacy Pharmaceutical Co., Ltd. (2289-HK) Stock Split, History Data
Working capital analysis
In terms of working capital, Charmacy Pharmaceutical Co., Ltd. maintains a healthy position.
The total current assets of the company are valued at $2811999921.
This represents a growth rate of 14.199% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $634197229, exhibiting a growth rate of 28.726% year-on-year.
The receivables, another significant portion of the current assets, are valued at $965351851.
The year-on-year growth rate for receivables is 11.568%.
The inventory, which forms a critical part of the assets, is valued at $775841635.
This represents a healthy year-on-year growth of 32.204%
On the liabilities side, the company's current liabilities total $2618858000.
This reflects a growth rate of 16.105% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
634.20
492.67
630.17
590.32
506.31
428.60
Receavebles
965.35
865.26
731.26
763.99
734.51
827.97
Inventory
775.84
586.85
509.16
585.01
515.16
472.52
Other
436.61
506.45
356.05
300.28
251.50
221.98
Total Current Assets
2812.00
2462.36
2238.22
2251.31
2018.70
1962.08
Acc Payable
659.07
876.78
809.77
938.61
833.56
778.93
Short Term Debt
1531.07
1390.03
1512.57
1509.05
1364.91
1166.83
Other Current Liab
2.53
1378.81
1349.16
1223.38
1044.70
1006.90
Current Liabilities
2618.86
2255.59
2158.92
2161.99
1878.26
1785.82
Capital Structure
When examining the capital structure of Charmacy Pharmaceutical Co., Ltd., it is clear that the company manages a robust portfolio.
These earnings represent the profits that Charmacy Pharmaceutical Co., Ltd. has chosen to reinvest in the business rather than distribute as dividends.
